Obesity is a significant risk factor for many chronic diseases, including cancer. Obesity is linked to about 4% to 8% of all cancers diagnosed annually in the United States. But is this message being communicated to patients?
In today’s world, there is always a new technology or innovation that is being touted as the next big thing. Plenty of hype surrounds new products, from artificial intelligence to weight loss drugs. However, it is essential to remember that not all hype is created equal. Some hyped products are revolutionary and can change our lives for the better. Others, however, are nothing more than overhyped buzzwords that will never live up to their promises.
The headlines stated that Lilly’s new weight loss pill provided exceptional clinical trial results. Still, we must determine whether patients exercised and followed a diet while taking the product. I had a chance to review some results of a recent ad board, which indicated that there may be some troubling trends behind the hype.
The United States spends more on healthcare than any other country globally, yet we have some of the worst health outcomes. One of the reasons for this is that the healthcare industry is highly profitable, and with an aging population, it will worsen.
New estimates published this week in The Lancet indicate that more than 1·31 billion people could live with diabetes by 2050 worldwide. That’s 1·31 billion people living with a disease that causes life-altering morbidity and high mortality rates and interacts with and exacerbates many other disorders.
Healthcare spending projections in the US are off the charts, and everyone wants some of that money. Pharma companies are suing to stop Medicare from negotiating drug prices, and Walmart and Amazon are testing the healthcare environment. It won’t necessarily lead to better healthcare, but it will lead to more profits.
The success rate of biotech startups is relatively low. According to a National Center for Biotechnology Information study, only about 18% of biotech startups make it to market. Only a tiny percentage of those that make it to market are successful enough to generate significant revenue.
Value-based healthcare is an approach to healthcare delivery that aims to improve patient outcomes while controlling costs. It emphasizes measuring outcomes that matter to patients and aligning payment and incentives with those outcomes. While value-based healthcare has shown promise in many areas, its effectiveness can vary depending on several factors.